The Blister Pack Bulletin: Britain Is Overdosing on Trump Headlines Without Reading the Leaflet

Every Friday, a new Trump story lands on the British doormat like a repeat prescription. It has a foil lid, a dosage, and a side-effect list nobody reads. The headline says CRISIS. The standfirst says ANALYSIS. The body says something about a rally, a courthouse, a tariff, a Truth Social post fired off at 3am. And somewhere in Britain, a reader nods, swallows the tablet, and asks the question the packaging never answers: what does this actually do for me, here, in 2026?

The Weekly Dose

We have developed a national habit of treating American politics as a mood-altering substance. Take one Trump panic after breakfast. Do not exceed four per day. If symptoms of relevance persist, consult your MP. May cause involuntary use of the phrase 'wake-up call' and a sudden urge to have an opinion about Ohio.

The problem is not that Trump is unimportant. The problem is that the packaging has become the product. A story can be legally sold in Britain as ' explosive' provided it contains at least 0.5mg of actual consequence and 499.5mg of studio debate. The rest is bulking agent: former advisers, anonymous sources, and a Reuters graphic of a swing state shaped like a kidney bean.

Active Ingredient or Bulking Agent?

A clinical-trial standard for transatlantic coverage would start with a simple box on every article. Active ingredient: what has changed in US law, policy, or market behaviour? Transmission belt: how does it reach Britain? Westminster decision: who here has to do something about it?

If the box cannot be filled in, the story is a placebo. It may still be entertaining. It may still be true. But it should be labelled as such, in the same way a packet of mints cannot claim to cure scurvy.

Consider the tariff announcement. Active ingredient: possible price changes for steel, cars, pharmaceuticals, whisky. Transmission belt: trade exposure, inflation, interest rates. Westminster decision: whether to retaliate, negotiate, or pretend the special relationship is a shield rather than a slogan. That is a real tablet.

Consider the rally footage. Active ingredient: none for Britain, unless the crowd size changes a Senate vote that changes a treaty that changes a base in Norfolk. Transmission belt: a cable news graphic. Westminster decision: none. That is a placebo with a sharp aftertaste.

Consider the court case. Active ingredient: possibly the rule of law, possibly a fine, possibly nothing. For Britain, the relevant question is whether it alters US foreign policy, trade posture, or the price of money. If not, it belongs in the entertainment section, next to the crossword.

A Yellow Card Scheme for Fleet Street

Britain already has a Yellow Card scheme for reporting side effects from medicines. We need one for headlines. Readers could log adverse reactions: elevated blood pressure, involuntary mentions of the special relationship, a compulsion to ring a phone-in and say 'what worries me is'. The regulator would publish a weekly bulletin. 'This week, 4,000 readers reported dizziness after a story about a Trump speech that contained no policy change. The outlet has been asked to add a leaflet.'

The scheme would be voluntary, like all the best British institutions, and ignored by the outlets that need it most. But it would at least give us a vocabulary. That story is not news. It is a sugar pill with a Fleet Street byline.

What the Label Would Actually Say

Trumpazine 24-hour news tablets. Indications: acute relevance anxiety. Dosage: one headline per hour, or two if the markets are open. Active ingredient: 0.5mg of UK consequence, 499.5mg of panel discussion. Warnings: may cause Brexit nostalgia, sudden expertise in American civics, and the belief that a US midterm result determines whether your council empties the bins.

Do not operate heavy machinery or a social media account after reading. Keep out of reach of columnists. If symptoms persist, read the accompanying leaflet, which has been printed in 4pt type on the back of a story about Melania's coat.

The British Symptoms

In 2026, the British symptoms are easy to spot. We can debate the composition of a Trump cabinet before we can name our own MP's position on the trade bill. We can quote a poll from Pennsylvania before we can explain what a US tariff does to the price of a van. We treat the special relationship as a pre-existing condition: chronic, manageable, and best discussed in whispers.

Britain watches Trump like a dog watches a magician. Fascinated. Suspicious. Entirely unsure where the sausage went. The coverage encourages this. It is easier to gasp than to calculate. Easier to say 'he is unpredictable' than to explain that a tariff schedule is a boring document with a measurable effect on a factory in Sunderland.

Dosage and Administration

A better reading routine requires three questions. What changed in US law or policy? What is the transmission belt to Britain: trade, security, interest rates, diplomacy, or nothing at all? Who in Westminster has an actual decision to make, and what are they pretending it is?

If the answers are 'nothing', 'none', and 'a select committee will write a letter', the story is a placebo. Bin it. Do not double-dose with a BBC package, a Times sketch, and a Guardian explainer. That way lies a headache and a wasted afternoon.

The Trial Protocol

Here is the trial. Twelve months. Outlets that wish to be taken seriously must print an Active Ingredient box on every Trump story. Readers are randomised into two groups. The treatment group sees the box. The control group sees the usual coverage. Endpoints: reduced blood pressure, increased knowledge of their own MP's position, and a measurable decline in the phrase 'this is a wake-up call for Britain'.

The placebo arm gets a weekly story about Luxembourg. If readers cannot tell the difference between Luxembourg and the latest Mar-a-Lago leak, we have our answer. The active ingredient was missing all along.

Trump is not a placebo. Much of the coverage is. The trick is not to ignore America. It is to stop swallowing the packaging. Read the leaflet. Name the ingredient. Then decide whether Britain needs the medicine, or just likes the taste of the panic.